PTX 7.14% 3.9¢ prescient therapeutics limited

One year from now, page-2

  1. 229 Posts.
    lightbulb Created with Sketch. 10
    Not knowledgeable, but I am happy to get the ball rolling with one measurable outcome
    For personal reasons, I would like to see:
    - a 2 or 3 antigen multi-centre Australian GBM clinical trial underway with Omnicar, using Cellpryme M, Cellpryme A, and utilising that 2-3 week post-infusion rest period like Kevin described. I think such a trial will seriously move the dial with GBM.




 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.003(7.14%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $75.11K 1.897M

Buyers (Bids)

No. Vol. Price($)
2 355874 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 75 1
View Market Depth
Last trade - 15.59pm 19/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.